Фармакологија и клинички испитувања

SafeSatyr avatar
SafeSatyr
·
·
Download

Start Quiz

Study Flashcards

3 Questions

Kako deluje G-protein na intracelularnite receptori?

Vozbujduva adenil ciklaza za sinteza na cAMP

Kade se locira domenot na protein kinazite na protein-tirozin kinaznite receptori?

Vo citoplazmatskiot domen

Koj od slednite funkcii e karakteristichen za duvanoksidul (NO)?

Podobruva aktivnosta na adenil ciklaza, zgolemuvaјki gi nivoite na cAMP i prouzrokuvaјki vazodilatacija

Study Notes

  • G-proteins bind to intracellular receptors, causing their conformational change and subsequent phosphorylation of GDP to GTP, leading to the release of an α subunit that activates adenyl cyclase for cAMP synthesis.
  • G-protein: a regulator; adenyl cyclase; lecithin; cAMP.
  • Apaf-1 protein induces apoptosis in cells.
  • Caspase activation: P53, Bcl-2, Apaf-1, and others.
  • For a non-linear drug, at constant dosing, the maximum concentration (Cmax) and half-life (T1/2) affect the elimination constant and area under the curve (AUC) disproportionately.
  • A large family of receptors with no extracellular domain includes; JAK/STAT is a tyrosine kinase receptor pathway.
  • The domain of protein tyrosine kinase receptors responsible for synthesizing protein kinases is located within the cytoplasmic domain.
  • Proteins and large insoluble molecules can be introduced into the body via _______ mechanism.
  • Agonists, antagonists, and inverse agonists are types of protein receptor drug interactions.
  • A biological model does not perfectly resemble human disease even if it has a similar genotype, pathophysiology, trigger, and therapeutic response.
  • Measuring a new compound's pharmacological activity: ligand binding assays, functional assays, toxicity, and pharmacodynamics.
  • The continuous addition of a drug dosage when receptors are saturated results in no change in the rate of drug excretion.
  • Adding an irreversible antagonist to an agonist decreases Cmax and increases Tmax, but AUC remains relatively unchanged.
  • G-protein signaling activation: Gα acts on GDP synthesis; Gαγβ binds to active G protein-coupled receptors; Gα is phosphorylated, turning GDP into GTP.
  • The deactivation of G-protein receptors: not specified in the text.
  • Nitric oxide (NO) functions: a) enhancing adenyl cyclase activity, increasing sGMP, and causing vasodilation; b) decreasing adenyl cyclase activity, decreasing sAMR, and causing vasodilation; c) decreasing adenyl cyclase activity, increasing sAMR, and causing vasodilation; d) enhancing adenyl cyclase activity, decreasing sAMR, and causing vasodilation.
  • Muscarinic receptors: a) M1; b) M2; c) M3; d) M4; e) M5; muskimol.

Ова прашање вклучува константата на рамнотежа при лек-рецептор интеракции, употребата на здрави пациенти во фазите на испитување и синтезата на втор гласник при реакција на инозитолтрифосфата+ фосфолипаза С.

Make Your Own Quizzes and Flashcards

Convert your notes into interactive study material.

Get started for free

More Quizzes Like This

Pharmacology Overview
10 questions
Clinical Pharmacology Overview Quiz
10 questions
Pharmacology: Drug Development and Safety
32 questions
Use Quizgecko on...
Browser
Browser